Status | Study |
Not yet recruiting |
Study Name: Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI) Condition: Brain Tumor Adult Date: 2017-02-16 Interventions: Drug: Hyperpolarized 13C-Pyruvate |
Withdrawn |
Study Name: NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse Condition: Adult Brain Glioblastoma Recurrent Adult Brain Neoplasm Date: 2015-01-22 Interventions: Procedure: Electric Field Therapy |
Recruiting |
Study Name: Longitudinal Metabolomic and Epigenetic Profiling of Bodyfluids From Patients With Lung and Brain Cancer Receiving Radiation Therapy Condition: Adult Brain Tumor Lung Cancer Date: 2014-09-11 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy Condition: Adult Brain Tumor Date: 2014-06-19 Interventions: Procedure: Arm I (light sedation) |
Recruiting |
Study Name: NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma Condition: Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gli Date: 2013-07-03 Interventions: Biological: Bevacizumab Bevaci |
Recruiting |
Study Name: Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma Condition: Glioblastoma Glioma Recurrent Adult Date: 2013-03-20 Interventions: Drug: sorafenib tosylate Given |
Active, not recruiting |
Study Name: Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Condition: Recurrent Glioblastoma Recurrent Adult Brain Tumor Date: 2013-03-18 Interventions: Biological: HSPPC-96 intraderm |
Completed |
Study Name: Prevalence of Post-craniotomy Headache in Siriraj Hospital Condition: Adult Brain Tumor Headache Date: 2013-03-03 |
Active, not recruiting |
Study Name: Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma Condition: Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gli Date: 2012-12-18 Interventions: Drug: dovitinib Given PO |
Completed |
Study Name: Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients Condition: Recurrent Glioblastoma Multiforme Malignant Glioma Date: 2012-11-28 Interventions: Drug: Vorinostat Other Name: S |